IRIS - Res&Arch Institutional Research Information System - Research & Archive

IORIO, Anna Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.781
AS - Asia 1.963
EU - Europa 1.866
SA - Sud America 355
Continente sconosciuto - Info sul continente non disponibili 141
AF - Africa 38
OC - Oceania 2
Totale 7.146
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.695
SG - Singapore 839
IE - Irlanda 379
UA - Ucraina 372
BR - Brasile 286
HK - Hong Kong 280
VN - Vietnam 253
CN - Cina 248
RU - Federazione Russa 238
DE - Germania 170
IT - Italia 159
FI - Finlandia 134
SE - Svezia 105
FR - Francia 104
GB - Regno Unito 80
KR - Corea 74
TR - Turchia 58
CA - Canada 48
IN - India 46
BD - Bangladesh 30
BE - Belgio 26
AR - Argentina 25
MX - Messico 24
PK - Pakistan 16
NL - Olanda 15
PL - Polonia 15
ES - Italia 13
SA - Arabia Saudita 13
ID - Indonesia 12
IQ - Iraq 12
CH - Svizzera 11
LB - Libano 11
CO - Colombia 10
UZ - Uzbekistan 10
AT - Austria 9
CZ - Repubblica Ceca 9
EC - Ecuador 9
JP - Giappone 9
MY - Malesia 8
CL - Cile 7
GR - Grecia 7
MA - Marocco 7
TN - Tunisia 7
VE - Venezuela 7
ZA - Sudafrica 7
JO - Giordania 6
PY - Paraguay 6
AZ - Azerbaigian 5
IL - Israele 5
LT - Lituania 5
RO - Romania 4
BG - Bulgaria 3
HN - Honduras 3
KE - Kenya 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CG - Congo 2
ET - Etiopia 2
GD - Grenada 2
HR - Croazia 2
JM - Giamaica 2
KH - Cambogia 2
NI - Nicaragua 2
PE - Perù 2
SC - Seychelles 2
TH - Thailandia 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GH - Ghana 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PW - Palau 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 7.002
Salva come PNG Salva come JPEG
Città #
Singapore 611
Chandler 383
Dublin 379
Hong Kong 280
San Jose 263
Jacksonville 216
San Mateo 181
Dong Ket 157
Ashburn 146
Santa Clara 103
Boardman 98
Ann Arbor 93
Moscow 85
Medford 77
Princeton 77
Munich 72
Lauterbourg 71
Beijing 68
Seoul 58
Wilmington 55
Andover 48
Ho Chi Minh City 41
Helsinki 39
Izmir 38
Los Angeles 34
São Paulo 31
Perugia 30
New York 29
Orem 25
Des Moines 24
Brussels 23
Saint Petersburg 21
Piscataway 20
Hanoi 19
Turku 19
Ottawa 18
Altamura 17
Genoa 17
Brooklyn 16
The Dalles 16
Woodbridge 16
Norwalk 15
Dongjak-gu 14
Frankfurt am Main 14
Houston 14
London 13
Chennai 12
Boston 11
Columbus 11
Florence 11
Shanghai 11
Lawrence 10
Montreal 10
Redwood City 10
Stockholm 10
Dallas 9
Manchester 9
Mexico City 9
Tokyo 9
Warsaw 9
Amsterdam 8
Buffalo 8
Chicago 8
Nuremberg 8
Ankara 7
Rio de Janeiro 7
Toronto 7
Amman 6
Atlanta 6
Belo Horizonte 6
Da Nang 6
Denver 6
Guarulhos 6
Redmond 6
Baku 5
Bogotá 5
Brasília 5
Dhaka 5
Düsseldorf 5
Falls Church 5
Fortaleza 5
Johannesburg 5
Lahore 5
Milan 5
Olomouc 5
Philadelphia 5
Poplar 5
Porto Alegre 5
Portsmouth 5
Rome 5
San Francisco 5
Seattle 5
Sorocaba 5
Tianjin 5
Auburn Hills 4
Baghdad 4
Calgary 4
Campinas 4
Caxias do Sul 4
Den Haag 4
Totale 4.444
Salva come PNG Salva come JPEG
Nome #
Antibody response and protection after intradermal and intramuscular 2011/2012 trivalent influenza vaccination in elderly volunteers 145
"Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age" 4th National Congress of the Italian Society of Virology (SIV) 141
" MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and elderly volunteers (winter season 2003/2004)" 141
An influenza A/H3N2 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home 134
Effect of age on serum heterologous antibody response elicited by inactivated influenza virus vaccine” 7th National Congress of the Italian Society of Virology 129
Antibody Responses after Influenza Vaccination in Elderly People: Useful Information from a 27-Year Study (from 1988–1989 to 2014–2015) 125
Influenza vaccination in patients on long-term anticoagulant therapy 125
[Colony inhibition test (C.I.T.) and the cytotoxic adherence test (C.A.T.): some comparative data]. 123
An influenza A/H3 outbreak during the 2004/2005 winter in elderlyvaccinated people living in a nursing home 120
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 120
An influenza B outbreak in elderly vaccinated people in the winter season 2007/2008” The Third European Influenza Conference 118
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59 adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. 117
Annually repeated influenza vaccination and humoral response in elderly volunteers. 116
Immunogenicità ed efficacia protettiva del vaccino influenzale per l’inverno 2007/08 in soggetti anziani residenti in casa di riposo” 36° Congresso Nazionale della Società Italiana di Microbiologia 114
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. 113
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age. 111
I benefici della vaccinazione influenzale Analisi e prospettive nella popolazione non anziana a rischio 110
An influenza A/H3 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home. 110
An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in Italy. 110
Antibody response elicited by 2012/2013 “implemented influenza vaccines”, FLUAD® (Novartis Vaccines & Diagnostics) and INTANZA® 15Mcg (Sanofi Pasteur MSD), in chronically ill institutionalized elderly volunteers 110
Antibody response against unchanged influenza vaccine components in elderly people vaccinated in consecutive years 107
Influenza vaccine immunogenicity and efficacy in istitutionalized elderly volunteers (winter season 2002/03). 105
[Natural resistance and induced resistance to ATPC + tumor in mice]. 105
Differente risposta anticorpale al vaccine anti-influenzale per l’inverno 2008/2009 in soggetti anziani residenti in due differenti case di riposo. 105
Clinical characteristics of influenza A/H1N1, A/H3N2 and B infections in children during three consecutive winter seasons (2012-13, 2013-14 and 2014-15) 105
Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. 103
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages 103
Induzione di risposta immunitaria e di protezione da parte dei vaccini antinfluenzali in soggetti anziani. 103
Immunobiological aspects of the nude mouse model relative to human cancer chemosensitivity tests. 102
[The serum protein picture in mice with ATPC ascites tumors studied by means of disk electrophoresis]. 101
Influenza vaccine induced antibody response against B influenza viruses included in the vaccine or naturally circulating during the winter season 2010/2011 99
Comparative study on immunogenicity among split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 99
Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (winters 2003/04 and 2007/08). 96
Immunogenicity of conventional trivalent inactivated influenza vaccines in pre-vaccination unprotected elderly volunteers in five winters seasons. 95
Proceedings of the X National Biotechnology Congress. 93
The effect of influenza vaccination in patients on long-term oral anticoagulant therapy 92
Comparative study of immunogenicity of split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 92
[Selective inhibition of the response to the allograft of a virus in mice] 91
Pro-inflammatory cytokines/ chemokines production after infection of A549 Human epithelial cell line with different strains of human influenza viruses 89
Immunization with adjuvanted and non-adjuvanted influenza vaccines of HIV-1 positive patients treated with highly active antiretroviral therapy (HAART) 88
MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and enderly volunteers (winter season 2003/04). 87
Pandemic Influenza A/H1N1pdm in Italy: Age, Risk and Population Susceptibility 86
Cross-reactive antibodies to viruses of both B/Victoria and B/Yamagata lineages as induced by influenza vaccination in middle-aged and elderly volunteers 85
Hospitalization associated with 2009 pandemic influenza A(H1N1) infection in Umbria, a region of central Italy, July – December 2009. 85
Influenza vaccine induction of cross–reactive antibodies against different B/Yamagata and B/Victoria-like influenza viruses. , 85
Twenty-seven years experience with immunogenicity of inactivated influenza vaccines in the elderly 84
Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) 84
null 83
Declined antibody response following influenza vaccination in elderly as compared with middle-aged volunteers: effects of aging and/or original antigenic sin? 82
The intersubunit region of influenza virus haemagglutinin as a peptide vaccine candidate. 82
Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. 81
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. 81
Immunogenicity of the MF-59-adjuvanted vaccine in volunteers of different group of age. 80
Influenza B virus circulation in elderly vaccinated people living in a nursing home in the winter season 2007/2008” 8th National Congress of the Italian Society of Virology 79
Synthesis and immuno-characterization of HSV-1 peptides for a potential vaccine 79
Induzione di anticorpi omologhi e cross-reattivi nei confronti di virus influenzali di tipo B da parte del vaccino influenzale nell'inverno 2003/2004 78
VALUTAZIONE DELL’EFFICACIA PROTETTIVA E DELLA CAPACITA’ DI INDURRE ANTICORPI CROSS-REATTIVI NEI CONFRONTI DI VIRUS INFLUENZALI DI TIPO B APPARTENENTI AI LINEAGGI YAMAGATA E VICTORIA DA PARTE DI DUE VACCINI INFLUENZALI TRIVALENTI (FLUAD® E INTANZA®) IN ANZIANI ISTITUZIONALIZZATI 77
Partial Protection Induced by 2011–2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People 77
Immunogenicity of influenza vaccine (1993-94 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users. 76
Serologically diagnosed influenza virus A/California/7/04 (H3N2)infection in people immunised with A/Fujan/411/2002(H3N2)antigen during the 2004/05 winter season 75
Seroprevalence against pandemic influenza A(H1N1) 2009 after the first season of circulation in Italy 73
Factors influencing humoral immune response after influenza vaccination in elderly and very elderly subjects 72
Increased immunogenicity of an adjuvanted influenza vaccine compared with a conventional subunit vaccine in non-elderly adult HIV seropositive individuals, treated with HAART 70
Intradermal and intramuscular 2011-2012 influenza vaccination of elderly institutionalized volunteers: induction of antibody responses against vaccine and epidemic influenza virus strains 70
Sorveglianza delle paralisi flaccide acute nella regione Umbria 70
Radioresistant Inhibition of Tumors (RIT): Biological and Pharmacological Studies 67
Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review 67
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus 67
Sorveglianza molecolare delle gastroenteriti da rotavirus in Umbria 66
ENDOGENOUS INTERLEUKYN-6 LEVELS AND ANTIBODY RESPONSE TO INACTIVATED INFLUENZA VACCINE IN PLURIVACCINATED ELDERLY VOLUNTEERS 64
Influenza A virus specific T cell immunity in humans during ageing 62
The new pandemic A/H1N1 influenza virus (pH1N1): celluler and humoral cross-reactive immune responses induced in healthy adults following 2007/2008 influenza vaccination. 61
Soggetti ricoverati in ospedale in Umbria con diagnosi di laboratorio di infezione da virus influenzale pandemico A/H1N1 nel periodo Luglio 2009 - Marzo 2010 61
Seroprevalence to the 2009 pandemic influenza a(H1N1) virus in the italian population after the 2009 pandemic (September/November 2010) 60
Laboratory confirmed pandemic H1N1 influenza virus infections in hospitalization in Umbria, a region of central Italy (May-November 2009). 59
Serological evidence of partial protection against infection with A/H3N2 circulating drifted strains after immunization with enhanced 2011/2012 trivalent influenza vaccines 56
Influenza vaccination in patients on long-term anticoagulant therapy 53
A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60–85 years old) and very elderly (>85 years old) institutionalized subjects 17
Totale 7.146
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.688
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.688
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022461 0 0 4 14 26 6 6 211 5 23 76 90
2022/20231.113 89 109 20 93 88 119 0 63 484 3 35 10
2023/2024483 32 45 30 9 3 1 125 28 71 4 86 49
2024/20251.144 15 114 31 59 181 38 46 36 223 78 196 127
2025/20262.234 167 149 84 281 282 218 380 107 329 166 56 15
2026/2027131 32 41 58 0 0 0 0 0 0 0 0 0
Totale 7.146